Biocon’s moment of reckoning
With biosimilars in the limelight, Kiran Mazumdar-Shaw’s company is poised to become one of India’s most important drug makers
21 April, 2020•12 min
0
21 April, 2020•12 min
0
More in Business
Business
Mankind needs to get its mojo back
Once a stock market darling, the pharma company is bearing the brunt of a costly acquisition.
You may also like
Business
Mankind needs to get its mojo back
Once a stock market darling, the pharma company is bearing the brunt of a costly acquisition.
Internet
In India’s Lenskart IPO, a success for ADIA
The sovereign wealth fund’s big bet on the Indian eyewear company, Microsoft’s AI win in the Emirates and other updates from the week.
Internet
Takeaways from Dubizzle’s rare pause on IPO
The classifieds company postponed its influential public listing on the Dubai stock exchange. A mismatch of expectations was at the core of it.